Brief: Telesis Bio Reports Third Quarter 2022 Financial Results

Telesis Bio

08/11/2022 22:41

Nov 8 (Reuters) - Telesis Bio Inc  DNAY.O :
    * TELESIS BIO INC. REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
    * CODEX DNA INC SEES FY REVENUE $23.0 MILLION TO $25.0
MILLION
    * CODEX DNA INC Q3 REVENUE ROSE 140 PERCENT TO $6.7 MILLION
    * CODEX DNA INC - INCREASES REVENUE GUIDANCE TO $23 MILLION
TO $25
MILLION FOR FULL YEAR FISCAL 2022
    * CODEX DNA INC - QTRLY LOSS PER SHARE $0.42
    * CODEX DNA INC - CASH ON HAND IS ANTICIPATED TO BE
APPROXIMATELY
$40 MILLION AT END OF 2022
    * CODEX DNA INC - AS OF SEPTEMBER 30, 2022, COMPANY HAD
$49.9
MILLION IN CASH, RESTRICTED CASH, CASH EQUIVALENTS AND
SHORT-TERM INVESTMENTS

Source text for Eikon:  ID:nGNX3v8N96 
Further company coverage:  DNAY.O 
 ((Reuters.Briefs@thomsonreuters.com;))